A B S -R A C T A procedure was developed for rneeasurement of androgeni receptors in cytoplasmic extracts of prostates froms intact dogs. The protocol utilized exchange saturatioin analysis at 15°C employing the synthetic androgen R1881 (17,8-hydroxy-17an-methylestra-4,9, 1 1-trien-3-one) as the ligand probe anid quantitatively dletected total cytoplasmic androgeni receptor (R, anidrogen-free receptor, and R,.A, androgenoccupied receptor) present at the initiation of the assay. This protocol was employed in conjunctioni with a tissue mince saturation anialysis procedure (for (uantitation of nuclear androgen receptor) to (quanititate total androgeni receptor content of normal and hyperplastic prostates obtained fromi young (2.5-or 4.6-yr old) and aged (12.5-yr old) purebred dogs of known birth date.
INTRODUCTION
The commoni occurrence of prostatic hyperplasia in man and the dog (1) (2) (3) , and advances in elucidation of Received for publicatiotn 3 June 1977 antd in revisedform 21 October 1977. the molecular mlechanismiis of hornmone action have led to an increasing number of investigations of hormonal regulationi of caniine prostate functioni (4) (5) (6) (7) (8) (9) (10) . Although histologic features (11) and hormone sensitivity (3, 4, (12) (13) (14) of the two prostatic hyperplasias differ, the induction of canine prostatic hyperplasia by injection of anidrostaniediol' or anidrostanediol plus 17,8-estradiol (9) suipports the use of the caniine model for studies of pathogenesis. When compared to normal prostates, 1)oth humilan anid caninle prostatic hyperplasia are characterized by an approximately fivefold increase (7, 15) in the conicentrationi of the prostatic androgen 5a-dihydrotestosterone (16) . However, the rate of conversion of testosterone to 5a-dihydrotestosterone is not significantly different for normal and hyperplastic prostates of either specie (7, 15) . The observations suiggest that an alteration in the mechanism of 5a-dlihydrotestosterone accumulation may be related to the pathogen esis of prostatic hyperplasia.
Current concepts of the mechanism of steroid hormone regulationi of cell function envisions a process whereby effector steroid initially interacts with cytoplasmic receptor proteins. The highly steroid specific b)inding of effector to cytoplasmic receptor protein promotes translocationi of the receptor-steroid complex into the nuclear compartment (17, 18) . Consequently, the capacity of the prostate to specifically accumulate 5a-dihydrotestosterone (effector steroid) would be expected to be related to the tissue cointenit of cytoplasmic and nuclear androgen receptor. As part of a study of aging-associated changes in steroid hormone 'Abbreviationts anid trivial names used in this paper:
canidrostanediol, 5a-androstane-3a, 17,(-diol, 3a, 17,8-dihydroxyandrostane; M4-androstenedione, 4-androstene-3, 17- clione; cortisol, 11,8,17a,21-trihydroxy-4-pregnene-3,20-dione; 5a-dihydrotestosterone, 1 7/8-hydroxy-5a-androstan-3-one; regulation of target tissue fuinction, we have characterized and quantitated androgen receptor content of normal and hyperplastic prostates of aging dogs. The results of these studies are the suibject of this communication.
METHODS
Aniimals. Mongrel dogs of indeterminiate age were used for protocol development. Definitive experimenits employed purebred dogs of known birth date. The 2.5-and 4.6-yr-old subject groups both consisted of three beagles obtained from Theracon, Inc., Topeka, Kans., and Marshal Research Animals, North Rose, N. Y., respectively. The 12.5-yr-old subject group consisted of two beagles, one obtained from Hazleton Research Animals, Cumilberland, Va., and the other from H. Barb Beagles, IInc., Essexville, Mich.; and one bloodhound obtained from the Texas Department of Corrections, Huntsville, Tex. None of the purebred dogs had been subjected to experimentationi before receipt at Southwest Foundation, where they were maintained in kenniels for a period of 3 wk to 3.5 yr before sacrifice. Mongrel dogs were orchiectomized as previously described (10) Centre de Recherches, Roussel-Uclaf, France. Purity of these compounds was monitored by thin-layer chromatography on silica gel employing benzene:ethyl acetate (1:1) as solvent. 7a-Methyl-A' 19-nortestosterone was generously provided by Dr. Albert Segaloff, Alton Ochsner Foundation, New Orleans, La. All other radioinert steroids were obtained from Steraloids, Inc., Wilton, N. H. and purity was determined as previously described (19). The preparation and storage of aqueous solutions of radioactive and radioinert steroids have previously been described (19). All other materials were the best reagent quality grade available from the manufacturer. Aqueous solutions were prepared in water which was distilled, deionized, and redistilled from glass.
Quantitation of available cytoplasmic anddrogen receptor sites (Re) in tissue from orchiectomized or intact subjects was achieved by saturation analysis as previously described (19, 20) with the exception that radiolabeled R1881 was employed as the ligand probe. Prostates from intact dogs were processed for the preparation of cytoplasmic extracts (cytosol) as previously described (10) . Endogenous steroids were removed from rat ventral prostate or canine prostate cytosol by mixing with a charcoal pellet obtained by centrifugation, 1,000 g for 5 min at 2°C, of 0.1 volume of 5%, Norit, 0.5% dextran T70, 1% human y-globulin in 50 mM TrisCl, 0.5 mM M,-mercaptoethanol, 0.1 mM EDTA, pH 7.4 . After a 10-min incubation at 2°C, charcoal was removed by centrifugation at 10,000 g (2 x 5 min) at 2°C, and the cytosol preparation was employed for determination of available (unoccupied, R,) and total (occupied, RCA, plus unloccupied, Re.) receptor sites. Saturation analysis (total sites) was accomplished by incubating triplicate 100-,1l aliquots of cytosol with 10 nM radiolabeled R1881 and sufficient radioinert R1881 to achieve the following final niaiionoolar concentrationis of ligan(d: 10, 15, 20, 30, 40, 50, 80, anid 11)0. After a 24-h incubation at 15°C, bounid radiosteroid wvas determined as previously described (10) . Nonspecific binding of R1881 was evaluated by incubating cytosol with 10 nMI radiolabeled R1881 plus 1 /I.L radioiniert R1881 andl the bound/ free ratio thus deterimined was employed to calculate nonsl)ecific binding of R1881 in all incubated samilples (21) .
Validationi of the cytoplasinic exchalnage protocol wats achieved employing cytosol prepared from orchiectomilized dogs (10) or rats (20) . The cvtosol was divided illto two portions and one was subjected to saturationi analysis (emiploying the ligand concenltrationis (lescribe(l above) for determliinationi of'R(. by incubationi with radiolabeled R1881 at 2°C for 2 h. The seconid portioin was incubated with 10 nM radioiniert R1881 for 1.5 h at 20C, treated with 5% Norit, 0.5%°dextrani T70, 1% huimani y-globulin in 50 mnM Tris-Cl, 0.5 mniM 8-miercaptoethanol, 0.1 mMnI EDTA, pH 7.4, and then subjected to saturationi analysis for dleterminaitioni of R(.A plus R(. by incubation with radiolabeled R1881 for 24 h at 15°C. Steroid specificity of the cytoplasmic androgen receptor was deteriniiied at 20 or 15°C by incubating the appropriate cytosol preparationi with 10 nNI radiolabeled R1881 and either 100 nM (2°C determiniations) or 500 nM (15°C determinatioins) competitor.
Saturation anialysis for determina(tioni of nuclear anidrogent receptor conitenit was performed as previously described (10) . Duplicate specimenis (200-500 mg) of each prostate were dried at 60°C in vaclUo unitil a constanit weight wais achieved. Total tissue contenit of DNA and(i RNA was determinied Uponl duplicate specimenis as previously descril)ed (19). Protein contenit was dleteriniiied for the cvtoplasmic extracts only (19).
Specimilens for histopathologic examiniiatioin were processe(il as previously described (22) . Radioactivity in all samilples was couinted to 2% precisioni as previously described (20) .
RESULTS
The assay proceduire was based uiponi the report of Bonnle and Raynaud (23) The results of a typical saturationi analyrsis for (Ioiantitatioin of n-uclear aildrogeni receptors in prostates froms intact purebred dogs are presenited in Fig. 1 B anid are comparable to our results previously reported for prostate fronm mongrel dogs (10) .
The prostates of the purebredcldogs were sepal-ate(d into two groups, miattre (4-14 g) and hyperplastic glands (>14 g) according to the criteria of Berg (3). Light microscopic examination showed that prostates from 2.5-and 4.6-yr-old dogs were principally composed of compact alveoli lined by intensely eosinophilic, graniular, culboidal-to-columnar epithelium. Intraluminal papillary projections of the epithelium were observed in some glands. Modest dilation of scattered alveoli or clusters of alveoli was observed. Thus, the histologic features of these specimens were those of normal mature canine prostates. Prostates from 12.5-yr-old dogs were principally composed of markedly dilated alveoli containing numerous papillary projections of epithelium. The epithelial cells were columnar and contained uniform, basally located, hyperchromatic nuclei. The lumens of some smaller alveoli were completely filled by papillary projections of epithelium and supporting stroma. The histologic Veatures of these specimens were characteristic of canine prostate hyperplasia.
The composition of prostates from 2.5-and 4.6-yr-old dogs, as measured by DNA, RNA, and protein content or percent dry weight, was indistinguishable (Table II) .
NIoreover, the mean number of cells per prostate and the RNA and protein contenit per cell was not significantly different for these two groups of dogs. Hyperplastic prostates from 12.5-yr-old dogs were distinguished from those of other subjects by a sevenfold increase in mass which was principally attributable to a greater than fivefold proliferation of cells as measured by DNA, RNA, and protein content (Table II) . In addition, there was a reproducible but not statistically significant (0.1 > P > 0.05) increase in the fluid content of hyperplastic prostates when compared to normal prostates. Significantly, the composition of hyperplastic prostates was indistinguishable from normal prostates when expressed as milligrams DNA, RNA, or protein per gram dry weight (Table II) . Available (R,) and total (RCA plus R,) cytoplasmic aindrogen-binding site content of the prostates from 2.5-and 4.6-yr-old dogs was not significantly different when measured either as picomoles per prostate or as sites per cell (Table III) . Nuclear androgen receptor sites per cell or content per prostate was significantly greater in prostates from 4.6-as compared to 2.5-yr-old dogs. The mean available or total cytoplasmic androgen-binding site content (picomoles per prostate) of hyperplastic canine prostates, respectively, was 5.2-or 4.6-fold greater than that of normal canine prostates. The mean nuclear androgen receptor content (picomoles per prostate) of hyperplastic canine prostates respectively was 5.0-and 7.8-fold greater than that of 4.6-and 2.5-yr-old dogs (Table III) . Significantly, androgenbinding site content per cell is identical for hyperplastic and normal canine prostates, with the exception that nuclear binding sites per cell in prostates from 2.5-yr-old dogs are significantly decreased (Table III) .
The steroid dissociation constants of the cytoplasmic androgen-binding sites or the ethanol-extractable portion of the nuclear androgen receptors of hyperplastic and normal canine prostates are not significantly Dry weight is expressed as percent of tissue obtained after removal of the urethra. § All data are based upon tissue weight after removal of the urethra. The DNA and RNA vallues represent total tissue content, whereas the protein value was only measured for the 100,000 g supernate of the tissue homogenate. ¶ Significantly different from the value for 12.5-yr-old dogs as determined by analyses of variance. Abseniee of symibol indicates absence of a significant difference. ** Weight range. 2,350+230 7,800+850 * As defined in Table II. t Cytoplasmic receptor sites were determined by saturation analysis employing radiolabeled R1881. Available sites were determined by incubation at 2°C for 2 h and total sites were determined by incubation at 15°C for 24 h. Nuclear sites were quantitated by mince saturation analysis at 37°C for 4 h employing radiolabeled 5a-dihydrotestosterone as probe. § Significantly different (P < 0.05) from the value for 12.5-yr-old dogs as determined by analyses of variance. Absence of an § indicates absence of a significant difference. 1 1 Significantly different (P < 0.05) from the value for 4.6-yr-old beagles.
different (Table IV) . A statistically significant increase in the dissociation constant of the KCl-extractable portion of the nuclear androgen receptors of prostates from 4.6-yr-old dogs was observed (Table IV) . Table II .
Ligand probe for cytoplasmic and nuclear saturation analyses, respectively, was radiolabeled R1881 and radiolabeled 5a-dihydrotestosterone. Data are the mean -+SEM for three independent determinations. § Significantly different (P < 0.05) from the value for 12. (7) who used a double isotope derivative technique for quantitation of canine prostate 5a-dihydrotestosterone content. The data support our conclusion that the saturation analyses are measuring physiologically significant binding componeints. The 5a-dihydrotestosterone content of the hyperplastic canine prostate is reported to be 1.60 ,g/100 g tissue (7) . Our data demonstrate that only 0.275 ,ug 5a-dihydrotestosterone per 100 g of hvperplastic prostate maximally may be bound to prostatic androgen receptors and thus suggest that >80% of the 5a-dihydrotestosterone content of hvperplastic canine prostates is not retained in association with prostatic androgen receptors. We conclude that caniine prostate hyperplasia is not a consequence of inereased accumulation of 5a-dihydrotestosterone due to proliferation of prostatic androgen receptors.
The current data demonstrate the absence of an aging-associated decrease in canine prostate androgen receptor content per cell. This observation is in complete opposition to that for rat prostate androgen receptors. We have demonstrated that ventral prostate cytoplasmic androgen receptor content in SpragueDawley and AXC rats, respectively, is diminished 50-65% at 2 yr of age and 85% at 3 yr of age (19, 20) .
Cy-toplasmic androgen receptor was not demonstrable in dorsolateral prostate of either breed of rat (19). Ventral and dorsolateral prostate nuclear androgen receptors evidenced a 35-50% aging-associated decrease in both breeds of rats (19). Additionally, we have identified spontaneous adenocarcinomas ofthe AXC rat ventral prostate, whereas this lesion was not found in the rat dorsolateral prostate (22, 25) . The incidence of this adenocarcinoma was 70% in AXC rats >30 mo of age (25) . It is interesting to speculate that the high incidence of prostatic hyperplasia and low incidence of adenocarcinoma of the prostate of the aging canine as compared to the absence of hyperplasia and high incidence of adenocarcinoma of the ventral prostate of the aging AXC rat is in some manner related to altered hormonal regulation of cell function which is reflected in the different relationship between aging and prostatic androgen receptor content in these two species.
